Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma
{{output}}
Introduction: Achievement of pathologic complete response (pCR) following neoadjuvant chemotherapy (NAC) in patients with pancreatic ductal adenocarcinoma (PDAC) is associated with improved overall survival (OS). However, the rol... ...
